Christophe Richez, Chantal Dumoulin, Thierry Schaeverbeke. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/immunologyAntirheumatic Agents/adverse effectsAntirheumatic Agents/immunologyArthritis, Rheumatoid/complicationsArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/pathologyAutoantibodies/bloodChilblains/complicationsChilblains/etiologyChilblains/pathologyFemaleHumansImmunocompromised HostInfliximabLupus Erythematosus, Cutaneous/complicationsLupus Erythematosus, Cutaneous/etiologyLupus Erythematosus, Cutaneous/pathologyMiddle AgedRaynaud Disease/complicationsRaynaud Disease/etiologyRaynaud Disease/pathology
Substances: See more » Antibodies, MonoclonalAntirheumatic AgentsAutoantibodiesInfliximab
Year: 2005 PMID: 15801042
Source DB: PubMed Journal: J Rheumatol ISSN: 0315-162X Impact factor: 4.666